Corpus Intelligence IC Memo — PIKES PEAK REGIONAL HOSPITAL 2026-04-26 14:10 UTC
IC Memo — PIKES PEAK REGIONAL HOSPITAL
Investment Committee Memorandum | CO | 13 beds | Grade C | EBITDA uplift $1.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PIKES PEAK REGIONAL HOSPITAL

CCN 061326 | TELLER, CO | 13 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

PIKES PEAK REGIONAL HOSPITAL is a 13-bed rural/critical access in TELLER, CO with $26.3M in net patient revenue and a -9.3% operating margin. The hospital serves a payer mix of 44.1% Medicare, 9.1% Medicaid, and 46.8% commercial.

Thesis: Turnaround. Our ML models identify $1.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -9.3% to -1.9% (+736bps).

Net Revenue HCRIS$26.3M
Current EBITDA COMPUTED$-2.4M
Operating Margin COMPUTED-9.3%
Occupancy HCRIS21.5%
Revenue / Bed COMPUTED$2.0M
Net-to-Gross HCRIS27.0%
Distress Probability ML54.8%

2. Market Context & Competitive Position

108
CO Hospitals
-3.6%
State Median Margin
35
Comparable Hospitals

CO has 108 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of -9.3% places it below the state median. Among 35 size-comparable peers (6-26 beds), the median margin is -5.1%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (6-26), prioritizing same-state peers. 35 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PIKES PEAK REGIONAL HOSPITAL (Target)CO13$26.3M-9.3%
NATIONAL JEWISH HEALTHCO13$150.4M-50.0%
ASPEN VALLEY HOSPITAL DISTRICTCO25$130.1M0.4%
HEART OF THE ROCKIES REG MED CCO25$117.5M5.4%
GRAND RIVER HOSPITAL DISTRICTCO25$85.2M-30.8%
CENTURA ST. THOMAS MORE HOSPITCO25$83.7M18.4%
SOUTHWEST MEMORIAL HOSPITALCO23$74.6M-4.5%
GUNNISON VALLEY HOSPITALCO20$63.3M2.8%
FAMILY HEALTH WEST HOSPITALCO25$62.6M6.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$552K+210bp18mo
Cost to Collect4.5%2.5%$526K+200bp12mo
Denial Rate Reduction12.0%6.5%$521K+198bp12mo
A/R Days Reduction5200.0%3800.0%$320K+122bp9mo
Clean Claim Rate88.0%96.0%$17K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$552K
Cost to Collect
$526K
Denial Rate Reduction
$521K
A/R Days Reduction
$320K
Clean Claim Rate
$17K
Total EBITDA Uplift$1.9M
Current EBITDA$-2.4M
+ RCM Uplift+$1.9M
Pro Forma EBITDA$-506K
Current Margin-9.3%
Pro Forma Margin-1.9%
WC Released (1x)$1.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-3.8M$3.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-3.8M$2.4M0.00x-100.0%
Bull Case9.0x11.0x$-3.4M$7.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-3.4M$7.2M0.00x-100.0%
Bear Case11.0x10.0x$-4.1M$-5.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-4.1M$-7.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 21.5%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 54.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 35 hospitals with 6-26 beds
  • Same-state prioritization (n=38)
  • Comp margins: P25=-24.1% / P50=-5.1% / P75=2.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.